Biogen

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$110.04-$207.59
Market Cap
$18.7B
Shares Short
3M

Financials

See more
Revenue (12 Mos)
$9.9B
Revenue Growth (YoY)
7.3%
Gross Profit (12 Mos)
$7.5B
Diluted EPS
$10.45

News

See more

Yahoo Finance • 9 hours ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

Yahoo Finance • yesterday

Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights

Yahoo Finance • 2 days ago

Biogen, Stoke Therapeutics Dose First Patient in Phase 3 Trial of Zorevunersen for Dravet Syndrome

Yahoo Finance • 2 days ago

Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome

About

CEO
Mr. Christopher A. Viehbacher
CFO
Ms. Robin C. Kramer
Address
225 Binney Street, Cambridge, MA, United States, 02142
Sector
Healthcare
Industry
Drug Manufacturers - General
Full-Time Employees
7,605